Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-12-20
Summary
study \& verify the hypothesis of the involvement of TSLP in the pathogenesis of vitiligo in comparison to their levels in the healthy control persons.
Conditions
- Vitiligo
Interventions
- OTHER
-
skin biopsy
Lesional skin biopsy was taken from every patient. Also a skin biopsy was taken from every control subject
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2017-07-31
- Completion
- 2017-07-31
More Related Trials
-
Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
NCT01511965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 ·Status: UNKNOWN ·Phase: NA
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079 ·Status: NOT_YET_RECRUITING
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation
NCT04843059 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Serological Markers of Vitiligo Activity
NCT06731283 ·Status: ACTIVE_NOT_RECRUITING
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
Leucotrichia in Vitiligo
NCT03402633 ·Status: COMPLETED
-
Vitiligo, New Treatment and Serum s100B
NCT06768840 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients
NCT07232238 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo
NCT05053022 ·Status: COMPLETED ·Phase: NA
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
Expression of Erythroid Differentiation Regulator 1 (Erdr1) in Vitiligo
NCT03377998 ·Status: UNKNOWN ·Phase: NA
-
Stress Response Pathways in Vitiligo
NCT02797574 ·Status: COMPLETED ·Phase: NA
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Janus Kinase 1 in Vitiligo & Psoriasis
NCT03762551 ·Status: COMPLETED ·Phase: NA
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
Human Beta-defensin 1 in Vitiligo
NCT03832751 ·Status: UNKNOWN ·Phase: NA
-
Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo
NCT03249064 ·Status: COMPLETED